Drug recall · September 29, 2021
Valproic Acid Oral Solution USP recall
Why: CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Valproic Acid Oral Solution USP, (250 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-621-16
- Lots / codes
Lot #: UV1159
- Quantity
- 38,748 bottles
- Company
- Morton Grove Pharmaceuticals, Inc., Morton Grove, IL
- Distribution
- Nationwide USA and China
- Initiated
- September 3, 2021 · Voluntary: Firm initiated
- Classified
- September 20, 2021
- Reported
- September 29, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.